Harlan Pinto

Clinical investigations focus on head and neck cancer with a particular interest in combined modality therapy. Through the Stanford University Head and Neck Tumor Board, clinical trials are conducted which involve all aspects of care for patients with head and neck cancer. The clinical research program includes translation of preclinical work performed in the Radiobiology Section at Stanford, new drug development, the development of novel combination therapy, chemoprevention, and the integration of biological response modifiers into combined modality treatment.

As a member of Stanford’s Eastern Cooperative Oncology Group trials effort, Dr. Pinto is involved in the implementation and development of a variety of clinical trials at Stanford and the Palo Alto Veterans Affairs Medical Center.